RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 163 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $300,000 | -71.7% | 100,000 | -65.7% | 0.01% | -75.0% |
Q3 2021 | $1,060,000 | +28.6% | 291,956 | +54.0% | 0.03% | +6.7% |
Q2 2021 | $824,000 | -45.2% | 189,600 | -56.9% | 0.03% | -18.9% |
Q1 2021 | $1,503,000 | +133.4% | 439,900 | +139.1% | 0.04% | +208.3% |
Q4 2020 | $644,000 | +257.8% | 184,000 | +145.3% | 0.01% | +100.0% |
Q3 2020 | $180,000 | – | 75,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 1,847,087 | $4,119,000 | 3.26% |
Sio Capital Management, LLC | 1,333,696 | $2,974,000 | 1.52% |
Boxer Capital, LLC | 700,000 | $1,561,000 | 1.38% |
Palo Alto Investors LP | 5,386,534 | $12,012,000 | 0.91% |
ACUTA CAPITAL PARTNERS, LLC | 747,748 | $1,667,000 | 0.80% |
SENZAR ASSET MANAGEMENT, LLC | 1,443,003 | $3,217,897,000 | 0.70% |
Ghost Tree Capital, LLC | 800,000 | $1,784,000 | 0.52% |
NEA Management Company, LLC | 3,243,150 | $7,232,000 | 0.38% |
Rhenman & Partners Asset Management AB | 850,000 | $1,896,000 | 0.34% |
Rock Springs Capital Management LP | 1,750,000 | $3,903,000 | 0.29% |